Cryo-Cell International Inc (CCEL)
7.92
+0.42
(+5.60%)
USD |
NYAM |
Apr 22, 16:00
7.70
-0.22
(-2.78%)
Pre-Market: 20:00
Cryo-Cell International Cash from Financing (TTM): -0.7611M for Feb. 29, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | -0.7611M |
November 30, 2023 | -2.073M |
August 31, 2023 | -6.098M |
May 31, 2023 | 1.655M |
February 28, 2023 | 0.947M |
November 30, 2022 | 0.1479M |
August 31, 2022 | 4.900M |
May 31, 2022 | -4.533M |
February 28, 2022 | -3.062M |
November 30, 2021 | -3.073M |
August 31, 2021 | -3.034M |
May 31, 2021 | -4.979M |
February 28, 2021 | -5.853M |
November 30, 2020 | -5.004M |
August 31, 2020 | -5.996M |
May 31, 2020 | -5.096M |
February 29, 2020 | -5.096M |
November 30, 2019 | -5.132M |
August 31, 2019 | -5.139M |
May 31, 2019 | 5.161M |
February 28, 2019 | 5.438M |
November 30, 2018 | 5.71M |
August 31, 2018 | 6.998M |
May 31, 2018 | -2.674M |
February 28, 2018 | -2.974M |
Date | Value |
---|---|
November 30, 2017 | -3.032M |
August 31, 2017 | -3.562M |
May 31, 2017 | -5.954M |
February 28, 2017 | -5.342M |
November 30, 2016 | -5.270M |
August 31, 2016 | -4.571M |
May 31, 2016 | -2.976M |
February 29, 2016 | -3.704M |
November 30, 2015 | -3.259M |
August 31, 2015 | -3.310M |
May 31, 2015 | -2.186M |
February 28, 2015 | -2.179M |
November 30, 2014 | -2.592M |
August 31, 2014 | -2.290M |
May 31, 2014 | -1.426M |
February 28, 2014 | -0.9285M |
November 30, 2013 | -0.7237M |
August 31, 2013 | -1.083M |
May 31, 2013 | -1.631M |
February 28, 2013 | -2.144M |
November 30, 2012 | -4.951M |
August 31, 2012 | -4.467M |
May 31, 2012 | -3.901M |
February 29, 2012 | -2.973M |
November 30, 2011 | 0.0809M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-6.098M
Minimum
Aug 2023
5.161M
Maximum
May 2019
-2.606M
Average
-3.803M
Median
Cash from Financing (TTM) Benchmarks
American Shared Hospital Services | 1.91M |
Novo Integrated Sciences Inc | 4.668M |
Astrana Health Inc | 3.421M |
P3 Health Partners Inc | 100.33M |
Biote Corp | -14.38M |